New ACS Cocktail: ASA, Antiplatelets, Beta-blockers, and Now Varenicline? New ACS Cocktail: ASA, Antiplatelets, Beta-blockers, and Now Varenicline?

Dr Melissa Walton-Shirley reports on the impressive results of the EVITA varenicline trial in the highest-risk population possible: MI patients in the hospital. theheart.org on Medscape
Source: Medscape Cardiology Headlines - Category: Cardiology Tags: Cardiology Expert Column Source Type: news